Blue Jay Capital Management’s QIAGEN NV QGENF Stock Holding History

Blue Jay Capital Management’s Portfolio QGENF Stock Details QGENF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-390,000	Closed	-$11.3M	–	30
2017 Q1	$11.3M	Sell	390,000 -48,572	-11%	-$1.41M	5.55%	5
2016 Q4	$12.3M	Buy	438,572 +138,572	+46%	+$3.88M	7.42%	2
2016 Q3	$8.23M	Buy	+300,000	New	+$8.23M	4.49%	16
2016 Q2	–	Sell	-475,000	Closed	-$10.6M	–	24
2016 Q1	$10.6M	Buy	475,000 +115,000	+32%	+$2.57M	6.79%	7
2015 Q4	$9.95M	Sell	360,000 -65,000	-15%	-$1.8M	3.36%	19
2015 Q3	$11M	Buy	425,000 +60,590	+17%	+$1.56M	4.31%	17
2015 Q2	$9.03M	Buy	+364,410	New	+$9.03M	2.43%	26

Other funds holding QGENF

PVI

Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return

Twin Tree Management Dallas, Texas $5.31B AUM 55.82% 1-Year Est. Return

Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return

FIM

Freedom Investment Management Hartford, Connecticut $359M AUM 23.01% 1-Year Est. Return

Blue Jay Capital Management's QGENF Position: Q2 2017 in Review

Blue Jay Capital Management sold out of QIAGEN NV (QGENF) in Q2 2017, closing a stake of 390,000 shares — an estimated $11.3M sold.

Blue Jay Capital Management first reported a position in QGENF in Q2 2015 and held it in 7 quarters. The position peaked at $12.3M in Q4 2016. 4 funds tracked by Wall St. Rank hold QGENF as of Q2 2017.

Blue Jay Capital Management reported no remaining QIAGEN NV position as of Q2 2017 after selling out during the quarter.
Blue Jay Capital Management sold 390,000 QIAGEN NV shares in Q2 2017, an estimated $11.3M.
Blue Jay Capital Management first reported a position in QIAGEN NV in Q2 2015 and held it in 7 quarters.
Blue Jay Capital Management's QIAGEN NV position peaked at $12.3M in Q4 2016.
4 funds tracked by Wall St. Rank held QIAGEN NV as of Q2 2017.

Based on Blue Jay Capital Management's 13F filing for Q2 2017, filed 11 Aug 2017.